I get an early memory from my dad which I say to myself every dayYou cant park up front unless you drive there. The bottom line is, nothing ventured, nothing gained. Youve got to go for it. Urgency is also kind of in my DNA, which is important for MDA right now. As a CEO driving this organization, you need somebody with urgency because every day that goes by that we dont treat these patients, they lose muscle and we are on the hunt to make a difference for every one of these patients.
I had the pleasure to interview Lynn OConnor Vos, the President & CEO of the Muscular Dystrophy Association. Lynn brings broad leadership capacity to the Muscular Dystrophy Association. She held her CEO position at greyhealth (ghg) for nearly 23 years and is credited with creating, building and acquiring companiesspecifically, nine acquisitionsto grow ghgs global footprint. While at ghg, Vos led global expansion and diversification strategies and within two years, grew the company from a small, domestic professional player into an award-winning global enterprise with fully integrated, multi-channel offerings. She is a recognized thought leader in the industry with published white papers and articles outlining new, successful approaches to health care technology and communications.
Thank you so much for joining us Lynn! Can you tell us a story briefly about what brought you to this specific career path?
I spent my entire career in healthcare, starting out as a pediatric nurse at Childrens Hospital of Philadelphia. Ive always been extremely interested in improving patient outcomes and really making a big difference in healthcare and had a dual track in my career. I did a lot of board work at the nonprofit level, including with the Multiple Myeloma Research Foundation, where I helped Kathy Giusti for 10 years. I was also a founding member of the Jed Foundation and there, our mission was to prevent suicide in teens and young adults, so I have had a tremendous nonprofit run from a board perspective.
At the same time, I ran a global healthcare communication firm called greyhealth, which had a focus on the pharmaceutical industry and focused on my interest level, which is entrepreneurialism. I just love to identify opportunities, gaps and new programs; a great example is text4baby which is the largest mobile health program for mothers. Mothers can use the program to track their due date and the progress of their pregnancy. That was a very successful program.
Fast forward to todaythe MDA came by as an opportunity. The MDA has been funding over a billion dollars of research and today, we have breakthrough therapies on the market, gene replacement therapy for SMA and many disease modifying therapies in the pipeline. I saw this opportunity as a chance to transform the organization and move them in the direction of driving cures and hopefully eliminating neuromuscular diseases someday through all the research we support.
My job is the perfect combination of carebecause I was a nurseand driving research. Not to mention the fact that you cant run an organization this size unless you can bring great marketing to bear.
Can you share the most interesting story that happened to you since you began leading your company?
The MDA is privileged to have had a significant number of sponsors who have been with us for decades. I think one of the most interesting stories was with one of our largest partners, the International Association of Fire Fighters. Last year, the first year I was at MDA, was the 100-year anniversary of the IAFF and I had this amazing opportunity to go to their anniversary in Seattle. I have to say I was completely blown awaythere was a massive movie and diorama and a gorgeous depiction of what the last 100 years have looked like from the firefighters perspective and how many amazing and challenging situations they have addressed, including 9/11. I was absolutely proud and privileged to be in the company of the general president Harold Schaitberger and his entire constituents. So, you join a nonprofit organization expecting to be very engaged in the medical community and fundraisers as well, but at MDA, we are very lucky to have some of the highly respected individuals in America working for us to drive fundraising for children with neuromuscular diseases.
Can you share a story about the funniest mistake you made when you were first starting? Can you tell us about the lesson you learned from that?
When I joined MDA, we were at a pivotal point where we had to turn to really focus on driving care and better treatment for patients. There was a lot of transition in certain departments. I cant say this is a funny mistake, but its certainly something every leader knows. My tendency as an individual and leader is, I always get in there and I want to fix things quickly. I think leaders have to adjust to understand the level of change management that might be necessary to actually get to that new place. We probably made the right move, but we probably could have slowed down in certain areas because we all know that change happens slower than that.
Are there three things the community, society and politicians can do to help you address the root of the problem youre trying to solve?
Our problem is a health problem and because there were no treatments for so long, we werent really mobilized to handle that. We can make it easier for people with our diseases to acquire all the treatments and devices they need to live a very successful and productive life. And I think were going to be looking at that more closely. We know we are committed to innovations in care. And when you think about care, were thinking about that broadly, even with their retail experience. Can we make a better retail experience for these individuals? For example, can we deliver all of the products they need on a timely basis? Can we bring community together so that they get best practices and best ideas of how to live with their disease through digital platforms?
In terms of politicians, society and community, we can have a lot of community engagementour IAFF and Jiffy Lube partnerships are locally driven (view our MUSCLE UP Campaign with Jiffy Lube here). Our intention is to do much more at the local level to connect and bring best in class services to individuals who have these diseases. And we also are moving in the direction of really understanding how we can create greater access for the drugs that are coming out. Thats something MDA is going to be looking at in the next year or so to actually get those care centers and bring those drugs to patients when they need them.
I also think that one of the most exciting things that definitely relates to the politicians and society is newborn screening. The way newborn screening works in America is you only get screened for four conditions where there are treatments and were starting to see that there are treatments now coming to market. And what were doing at MDA is mobilizing the entire community along with our chairman, whos devoted his life to newborn screening, to get newborn screening implemented across America. Those decisions are made federally, and the HHS has approved two of these. The next level is to actually go out and lobby every state and make sure that they adopt this practice. And so, what we need help with is local and national politicians to lobby for us. On the local level, we need to make sure that every baby is screened for these matters. If theyre screened at birth, and they are identified right away, and they get a drug for replacement therapy, for example, or disease modern modifying therapy, they will, in some cases, be cured of the disease. Because every day that they dont get treated, another motor neuron dies. Its really urgent to get newborn screening done right away.
How do you define leadership? Can you explain what you mean or give an example?
I think the best leaders are really good listeners and that doesnt always come naturally with people who have strong leadership traits. Its something that I certainly work on every day. But a leaders job is to really set the course to make a bold move, identify where we should be going and then hire incredible peopleteam members who want to work together. Those are people that complement each other in terms of skills. They shouldnt be all the same mindset. It should be a diversified team in terms of skills and everything else coming together and really the leader needs to be open to all of their input to meet that bold move.
I would also say that when youre a leader in a situation where youre trying to do a transformation, which is what were doing, you have to be extremely concerned that youre reaching high enough. To me, that makes you think if your move is bold enough and rooted in reality. Secondly, you really need to make sure that people have the right skill set to make that bold move. And third, which is where I think a lot of transformations fail, is an exquisitely designed and implemented change management program. A great example of leadership is the CEO of Microsoft. You know when you read his book Refresh, he talks about the pivotal moment in his life when he had a son born with cerebral palsy. But the charter and the mission and the vision to address accessibility and technology in the way that Microsoft is going about it is just really impressive.
What are your five things you wish someone told you when you first started and why? Please share a story or example for each.
I hadnt really understood the power of MDAs research and care. This week, I got a call from the CEO from AskBio. He called specifically to tell me that MDA was the only funder out there in the early 2000s right after there had been some setbacks in gene therapy, and he was looking for funding for his research, and we were the one that gave him the funding and convinced them to start. He also articulated very clearly the effect of MDAs research dollars, the conviction that we had with him and the support we gave them. I wish I had known a little bit earlier on how spectacular the research program that MDA has committed to really is. We all need to understand how important nonprofits can be in transforming disease. And this is what MDA has done. I want more people to know the absolutely critical role MDA has played over the last 70 years in terms of bringing cures to markets. The other story I would say is, you know social impact is obviously so attractive to me and in fact to others. You want to make a big difference. You want to really transform the lives of individuals working with neuromuscular disease in this case. What you dont really understand when you jump into a job like this is the absolute enormous task of engaging with donors and driving fundraising. We have to fund every single piece of the mission and that is a very big challenge. Its also an opportunity. But it goes with the territory.
You are a person of enormous influence. If you could inspire a movement that would bring the most amount of good to the most amount of people, what would that be? You never know what your idea can trigger.
You look at all of the people that fundraised for us over the yearsthree hundred thousand firefighters, Harley Davidson, Jiffy Lube. We serve 250,000 patients and most of those people come to the MDA website to get information. Fifty thousand of those people go to MDAs clinics. Thousands of doctors are treating patients. We really believe at this point we need to create a movement. We are driving to bring to market, bring better care to our patients. And we want everyone out there to join us in this movement. And thats our big challenge going forward and a great opportunity in terms of marketing positioning. Were taking this brand that was known for Jerry Lewis. We now need to say, Join us again and help us to help others move again.
Can you please give us your favorite Life Lesson Quote? Can you share how that was relevant to you in your life?
I get an early memory from my dad which I say to myself every dayYou cant park up front unless you drive there. The bottom line is, nothing ventured, nothing gained. Youve got to go for it. Urgency is also kind of in my DNA, which is important for MDA right now. As a CEO driving this organization, you need somebody with urgency because every day that goes by that we dont treat these patients, they lose muscle and we are on the hunt to make a difference for every one of these patients.
Is there a person in the world or in the U.S. whom you would love to have a private breakfast or lunch with?
The CEO of Microsoft, because I find him to be an inspiring leader. What hes done at Microsoft is transformative. And the MDA is the right organization to partner with Microsoft because they want to make technology accessible for all. We service 250,000 people who want to work with technology. I think that our MOVR initiative is a great example of connecting all the care for patients that we can so that we can accelerate clinical trials and accelerate treatments to the right patient at the right time. And certainly, Microsoft is in that area of big data and A.I. The other thing thats really fun and something that weve done with Microsoft is that they have the adaptive controller that they launched last year at the Super Bowl. And weve done some really great gaming events at MDA Lets Play. Id love to talk to him about it because I think what Microsoft is doing is really impacting in a very positive way the children with neuromuscular disease and we just want to do more together. Hes also just an impeccable leader. Id love to learn from him.
Please visit MDA.org to learn more about MDA.
Read more from the original source:
Social Impact Heroes: How Lynn OConnor Vos and the Muscular Dystrophy Association are helping to raise billions of dollars to fund research to...
- Global Thalassemia Treatment Market is estimated to be US$ 14.7 billion by 2030 with a CAGR - GlobeNewswire - May 3rd, 2021
- Cell and Gene Therapy Market Opportunities, Recent Industry Size and Share Analysis With Forecast To 2027 | Dendreon, Vericel, Spark Therapeutics,... - May 3rd, 2021
- Searching for the Causes and Cures of Spinocerebellar Ataxias - University of Utah Health Care - May 3rd, 2021
- Global Negative Pressure Wound Therapy Market In-deep Analysis And Experts Review Report 2021-2024 Clark County Blog - Clark County Blog - May 3rd, 2021
- Antidepressants Market Size 2021 | Is Projected to Reach USD 18.29 Billion by 2027, Exhibiting a CAGR of 2.9% during 2020-2027 - GlobeNewswire - May 3rd, 2021
- Johnson & Johnson's COVID-19 vaccine has been paused in Colorado. Here's what you need to know. - The Denver Channel - April 18th, 2021
- Global Alpha Thalassemia Market 2021 Industry Insights, Drivers, Top Trends, Global Analysis And Forecast to 2027 NeighborWebSJ - NeighborWebSJ - April 18th, 2021
- Canavan Disease Treatment Market Growing Demand with Innovative Ideas Adopted by Key Players Johnson & Johnson Services, Inc., GlaxoSmithKline... - April 18th, 2021
- Cystinuria Treatment Market In-depth Research Covering Share Analysis, Industry Overview and Forecast | Key Players Retrophin, Inc, Mission Pharmacal... - April 18th, 2021
- Global Botulinum Toxin Market Size 2021 | To Hit USD 7.71 Billion at 7.5% CAGR by 2027; Increasing Awareness about the Therapeutic Benefits of Botox... - April 18th, 2021
- Adrenoleukodystrophy Treatment Market to Rise with Impressive CAGR | Players Viking Therapeutics, Nutra Pharma Corporation, Genetix Biotech Asia Pvt.... - April 18th, 2021
- Gene Therapy for CNS Disorders Market 2021 Industry Size, Share, Growth and Top Companies Analysis- Gilead (Kite Pharma), Amgen (BioVex), Novartis,... - April 4th, 2021
- Top Executives from AveXis Join New Gene Therapy Venture -- This Time Targeting Tens of Millions More Patients - PRNewswire - April 4th, 2021
- Gene Therapy for Hemophilia Market will Reach Thriving Value by 2019 to 2028 SoccerNurds - SoccerNurds - April 4th, 2021
- Hemophilia Treatment Market Analysis to 2025 - Growth Trends and Changes Influencing the Industry - Technology Magazine - February 9th, 2021
- Alpha Thalassemia Market Global Production, Growth, Share, Demand and Applications Forecast to 2027 NeighborWebSJ - NeighborWebSJ - February 9th, 2021
- Global Retinitis Pigmentosa (Retinitis) Market demand with COVID-19 recovery analysis 2021 better delivery process to boost market growth by 2026 KSU... - February 4th, 2021
- ASCO Names Molecular Profiling in GI Cancers as Advance of the Year - OncLive - February 4th, 2021
- Circularity Healthcare Announces Expansion with Global CRO of Series of Successful Pivotal Human Clinical Trials to Study Use of D'OXYVA for Rapid,... - February 2nd, 2021
- Parkinson's disease treatment Market Global Industry Analysis, Size, Share, Trends, Segmentation and Forecast 2021 2027 KSU | The Sentinel... - January 27th, 2021
- The Head And Neck Cancer Therapeutics Market to shirk economic slowdown between 2016 and 2024 Murphy's Hockey Law - Murphy's Hockey Law - January 27th, 2021
- Global Phenylketonuria (PKU) Treatment Market Detailed Analysis of Current Industry Figures with Forecast Growth By Top Competitors:American Gene... - January 23rd, 2021
- Global MRD (Minimal Residual Disease) Testing Market Report 2020-2025: One of the Most Rapidly Evolving and Dynamic Markets - GlobeNewswire - January 23rd, 2021
- Aerosol Masks Market to Witness Huge Growth by 2030 - KSU | The Sentinel Newspaper - January 19th, 2021
- Global Clinical Laboratory Services Market Analysis With Key Players, Applications, Trends And Forecasts 2028 - KSU | The Sentinel Newspaper - January 19th, 2021
- Alpha Thalassemia Market Outlook 2021 Witnessing Enormous Growth with Recent Trends & Demand | Regions are Bluebird Bio, Novartis, Kiadis Pharma,... - January 5th, 2021
- FABRY DISEASE MARKET 2020 2023 PROJECTED TO GROW RADIANTLY BY TOP PLAYERS REVENUE AND GROWTH RATE - Factory Gate - January 5th, 2021
- 2020 Highlights the Disparities and Discrepancy of Sickle Cell Care - MD Magazine - December 31st, 2020
- Gene Therapy Market 2020: Demand Analysis, Key Players, Trends, Sales, Supply, Deployment Model, Segments, Organization Size, Production, Revenue Data... - December 31st, 2020
- Global Stem Cell Manufacturing Market Research Study including Growth Factors, New Top Players, Competitive Analysis by regions from 2020 to 2027 -... - December 31st, 2020
- Global Brain Tumor Treatment Market Proceeds To Witness Huge Upswing Over Assessment Period by 2025 - The Courier - December 19th, 2020
- Global Gene Therapy Market Report 2020-2030 Featuring Novartis, Bluebird Bio, Spark Therapeutics, Audentes Therapeutics, Voyager Therapeutics,... - December 18th, 2020
- Gene Therapy Market Worth USD 35.67 Billion at 33.6% CAGR; Rising Prevalence of Spinal Muscular Atrophy to Augment Growth: Fortune Business Insights -... - December 18th, 2020
- Worldwide Industry for Cystic Fibrosis Therapeutics to 2025 - Players Include AbbVie, Alaxia and Alcresta Therapeutics Among Others - Stockhouse - December 18th, 2020
- Elidah Becomes the Only US Company to Win a Top Ten Prize in a Global Start-up Competition, Advancing Recognition for Women's Health - PRNewswire - December 18th, 2020
- Global Gene Therapy Market Report 2020: Non-COVID-19 Care Delivery Bears the Brunt of the Pandemic - Gene Therapy Market Slumps by -13.6% -... - December 3rd, 2020
- Global Gene Therapy Market Report 2020-2027: Market is Projected to Reach a Revised $3.3 Billion - GlobeNewswire - December 3rd, 2020
- 2020 Top 10 Innovations - The Scientist - December 3rd, 2020
- Global Regenerative Medicine Market to Rise Impressively at 26.1% CAGR and Hit USD 151,949.5 Million by 2026; Integra's Latest Product Offerings to... - December 3rd, 2020
- Precision Cancer Therapies Market Report 2020: Top Companies, Regions, Driving Force and Forecast 2026 - The Market Feed - December 3rd, 2020
- Hemophilia Treatment Market Research Report Forecast to 2029 (Includes Business Impact of COVID-19) - Cheshire Media - December 3rd, 2020
- Global Contract Cell and Gene Therapy Manufacturing Market Report 2020-2026: CDMO Categorization - Primed for Business Model Disruption - Benzinga - November 26th, 2020
- Internet hawkers of stem cell therapies raising red flags - Ophthalmology Times - November 26th, 2020
- Details are everything: Where is Ottawas COVID-19 vaccination plan? - The Globe and Mail - November 26th, 2020
- Impact of Covid 19 On Brain Tumor Treatment Market 2020 Industry Challenges Business Overview And Forecast Research Study 2026 - The Market Feed - November 26th, 2020
- Global Gene Therapy Industry - GlobeNewswire - November 20th, 2020
- Children's Hospital delivers life-saving gene replacement therapy to infant - Loma Linda University Health - November 20th, 2020
- Global Precision Cancer Therapies Market 2020: Analysis, Industry Growth, Current Trends and Forecast till 2025 - The Daily Philadelphian - November 20th, 2020
- Cutting-edge Treatment Offers Hope to Infant With Spinal Muscular Atrophy - Adventist Review - November 20th, 2020
- Molecular Testing With Universal Method Comparable to Traditional Method in Hereditary Solid Tumors - Targeted Oncology - November 20th, 2020
- Alpha Thalassemia Market Research Provides an In-Depth Analysis on the Future Growth Prospects and Industry Trends Adopted By the Competitors |... - November 20th, 2020
- Intrathecal Pumps Market 2020 Industry Size and Share Evolution to 2026 by Growth Insight, Trends - The Daily Philadelphian - November 20th, 2020
- $30 billion to fight COVID-19 over next five years - Sydney Morning Herald - November 20th, 2020
- Global Contract Cell and Gene Therapy Manufacturing Market 2020-2026: Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing... - November 12th, 2020
- Gene Therapy Market Size Is Estimated to Grow at a CAGR of 40.7% By 2025 | Sales Statistics, Future Trends, Business Overview and COVID-19 Impact... - November 12th, 2020
- Homology Medicines Announces Presentation of Positive Data from the Dose-Escalation Phase of the pheNIX Gene Therapy Trial for Adults with PKU -... - November 12th, 2020
- Magnetic Resonance Imaging Market Growth Estimation, Future Insights, Applications, Key Players, Size Analysis, COVID-19 Impact and MRI Industry... - November 12th, 2020
- Choroideremia Treatment Market Share Analysis by Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc - Sunrise Nigeria - November 12th, 2020
- Homology Medicines Announces Upcoming Oral Presentation on pheNIX Gene Therapy Clinical Trial for Adults with PKU - GlobeNewswire - November 11th, 2020
- Homology Medicines Announces Presentation of Positive Data from the Dose-Escalation Phase of the pheNIX Gene Therapy Trial for Adults with PKU | DNA... - November 11th, 2020
- COVID vaccine to be rolled out within months: Hunt - Daily Mercury - November 11th, 2020
- Blockchain offers advanced therapy tracking - Bioprocess InsiderBioProcess - BioProcess Insider - November 5th, 2020
- Flexion Therapeutics Reports Third-Quarter 2020 Financial Results and Recent Business Highlights - GlobeNewswire - November 5th, 2020
- Lynparza approved in the EU as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer | Small Molecules | News... - November 5th, 2020
- Predictive Biomarkers Market Growth Sales Revenue Analysis 2020-2025 - The Think Curiouser - November 5th, 2020
- Retinitis Pigmentosa (Retinitis) Market Report 2020 (COVID-19 Impact Analysis) By Segmentations, Key Company Profiles & Demand Forecasts to 2020 ... - November 5th, 2020
- Hyperbaric Oxygen Therapy (HBOT)Market: Is Covid19 testing the healthcare industry? - PRnews Leader - October 29th, 2020
- Coronavirus Outbreak: C-Arms Industry Fights Back with Well-defined Business Strategies - PRnews Leader - October 29th, 2020
- The good news about breast cancer - The Gazette - October 29th, 2020
- Retinitis Pigmentosa (Retinitis) Market Analysis by 24 Key Players, Types, Applications and Growth Opportunities to 2025 - The Think Curiouser - October 29th, 2020
- Choroideremia Treatment Market Trend & Growth by Copernicus Therapeutics, Inc, Wize Pharma Inc, Spark Therapeutics, Inc - PRnews Leader - October 24th, 2020
- Precision Cancer Therapies Market Research on Precision Cancer Therapies Market 2019 and Analysis to 2025 - PRnews Leader - October 24th, 2020
- Clinical Laboratory Services Market 2020-2027 Strong Revenue and Competitive Outlook By Top Leaders : Mayo Foundation for Medical Education and... - October 17th, 2020
- CHOROIDEREMIA TREATMENT MARKET BUSINESS GROWTH BY COPERNICUS THERAPEUTICS, INC, WIZE PHARMA INC, SPARK THERAPEUTICS, INC - PRnews Leader - October 17th, 2020
- Cryopreservation Equipment Market: Increase in Demand for Regenerative Medicines to Accelerate Market Growth - BioSpace - October 10th, 2020
- Cartilage Repair/ Cartilage Regeneration Market worth $1,603 million by 2025 - Exclusive Report by MarketsandMarkets - PR Newswire UK - October 10th, 2020
- Pediatric Neuroblastoma Treatment Market Share Worldwide Industry Growth, Size, Statistics and Opportunity During 2020 to 2026 - Press Release -... - October 10th, 2020
- NMDP/Be The Match partners with M Health Fairview and Duke University cryopreservation labs to launch Be The Match BioBank - Watauga Democrat - October 7th, 2020
- What Will Be Driving Growth of Alpha Thalassemia market Near Future By Top Vendors Like | Bluebird Bio, Novartis, Kiadis Pharma, Acceleron Pharma ,... - October 7th, 2020
- Cancer Therapy Market Research by 2020 Top Countries Data, Key Players, Industry Revenue, Demand Status and Investments Plans Forecast to 2024 - The... - October 7th, 2020
